I am currently Director of the Centre for Clinical Sciences for HYMS. I am also member of the TRANSFORM Faculty with a link role for the Cancer Research group and the Hull molecular imaging Centers (HuMIC). I have a long and fruitful collaboration with basic scientists in UoH faculty of health sciences (FHS) having supervised a number of PhD and MD projects in translational research mostly involving the interface between the coagulation pathways and cancer cell metastasis with the molecular role of Tissue Factor (TF) in the propagation of cancer being key. More recently we have introduced medical informatics platforms to our work in collaboration the HPC(Viper) team to study the carcinogenic process in pancreatic cancer.
I graduated from Athens Medical School in 1983 and completed internal medicine training in 1990. In 1995 I was awarded my PhD from the University of London on monoclonal antibodies in Head and Neck Cancer. I completed my cancer specialty training as a lecturer at St George's hospital studying the immunology of melanoma cell vaccine therapeutics. I was appointed as a Senior Lecturer at the University of Hull in 1999 part of the founding team of Hull York Medical School, where I became professor of Cancer Medicine in 2012.
I am also a honorary consultant in the Hull University Teaching Hospitals NHS Trust (HUTH) having also been the Director of R&D till 2021. I treat and am involved in clinical trials in pancreaticobiliary, kidney cancer and melanoma and have particular clinical and basic science research interest in cancer associated thrombosis (CAT).
I have been national and international chief investigator for a number of studies in CAT and have worked on international guideline bodies for this condition. I have published widely in CAT with particular focus on the thromboprophylaxis of the ambulatory cancer patient and the management of incidental pulmonary embolism in cancer patients.
Click here to see Professor Maraveyas' publications
Currently 4 PhD students:
NIHR ACF PhD studentship subject to successful application:
Co Chair on the ISTH SSC (Scientific Standardization Committee) for Cancer and Thrombosis
Member of the ESMO CAT Guidelines Working Group
Member of the CAT guidelines Task Force for the BSH
National Chief Investigator for the APICAT study